http://www.pharmachemm.com
Home > Recommended

Quality for China Apixaban Intermediate,Gout Treatment Powder,Eliquis Raw Material Apixaban Manufacturer Imatinib Mesilate api cas 220127-57-1 cas 152459-95-5 export to Nepal Suppliers

Share to:  
    Incoterm: FOB,CIF
    Min. Order: 1 Bag/Bags
    Delivery Time: 1 Days
  • Product Detail
  • Product Tags
  • Buyer Reviews

We try for excellence, company the customers", hopes to be the best cooperation workforce and dominator enterprise for personnel, suppliers and clients, realizes value share and steady marketing for Imatinib Mesilate API IMatinib-D4,Imatinib Base Gleevec Pills,Imatinib Mesilate Intermediate. Welcome any inquiry to our firm. We will be happy to ascertain helpful business enterprise relationships along with you!

Quality for China Apixaban Intermediate,Gout Treatment Powder,Eliquis Raw Material Apixaban Manufacturer Imatinib Mesilate api cas 220127-57-1 cas 152459-95-5 export to Nepal Suppliers

Imatinib is a small molecule kinase inhibitor used to treat certain types of cancer. It is currently marketed by Novartis as Gleevec (USA) or Glivec (Europe/Australia) as its mesylate salt, imatinib mesilate (INN). It is occasionally referred to as CGP57148B or STI571 (especially in older publications).Product Name: Imatinib Mesilate

CAS NO: 220127-57-1

Standard: Enterprise Standard

Molecular Formula: C30H35N7O4S

Molecular Weight : 589.71

Description: White crystal or crystalline powder

Package :25KG/drums

Chemical names, synonyms:


4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate, STI-571, IMATINIB BASE(IMA-3), Imatinib (STI-571) Mesylate



Minimum purity: 99%

 Imatinib Mesilate 220127-57-1

 

 

Description

White to off-white Crystalline Powder

Identification By IR

IR spectrum of the sample should concordant to the standard spectrum.

Solubility

Soluble in Water

LOD

NMT  0.5% w/w

Related substance

by HPLC

Single Max. Imp              : NMT  0.1 %

Total Max Imp                : NMT  1.0 %

Assay (By HPLC)

NMT 98.0% And NLT 102 %

ROI

NMT  0.5%

Heavy metals

NMT 0.5%

Thermo gram

220-227ºC

Imatinib Mesylate is a targeted therapy. Imatinib Mesylate is classified as a signal transduction inhibitor - protein-tyrosine kinase inhibitor.

A methanesulfonate (mesylate) salt that is the monomesylate salt of imatinib. Used for treatment of chronic myelogenous leukemia and gastrointestinal stromal tumours.

Imatinib mesylate (also called Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl, the causal agent in chronic myelogenous leukemia.

As an inhibitor of PDGFR, imatinib mesylate appears to have utility in the treatment of a variety of dermatological diseases. Imatinib has been reported to be an effective treatment for FIP1L1-PDGFRalpha+ mast cell disease, hypereosinophilic syndrome, and dermatofibrosarcoma protuberans.



"Having a sound business enterprise credit score, outstanding after-sales assistance and modern producing facilities, we have now earned an exceptional name among our shoppers across the planet for 20127-57-1 Mesilate cas 152459-95-5. The product will supply to all over the world, such as: North Korea,Comoros,Liechtenstein. With a team of experienced and knowledgeable personnel our market covers South America, the USA, the Mid East and North Africa. Many customers have become our friends after good cooperation with us. If you have the requirement for any of our products please contact us now. We are looking forward to hearing from you soon.

Email To This Supplier

Your message must be between 20-8000 characters

YOU MAY LIKE

Communicate with Supplier?Supplier
Mr. Vid Mr. Mr. Vid
What can I do for you?
Contact Supplier